You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Skin tone equity in tech performance
Medtronic believes healthcare technology shouldn’t discriminate. We’re leading with purpose, expanding access to healthcare, and making an impact toward achieving health equity.
Oxygen saturation is now considered the fifth vital sign across all areas of care. Our Nellcor™ pulse oximeters lead the way in equitable patient monitoring and offer greater SpO2 accuracy than Masimo for patients with dark skin tones.†,1 We are taking the impact further by advancing the technology, building lasting partnerships and investing in education to reduce the discrepancies in pulse oximetry. Our goal is clear — to enable the best care for every patient. We’re on it.
Accuracy based on study, not funded by Medtronic, that enrolled 146 healthy subjects in the 92–96% saturation range and examined paired readings from Nellcor™ N-595 and market competitor pulse oximeters generated simultaneously. This study was not designed for head-to-head comparison of the respective devices.
We’re always innovating because technology has the power to eliminate barriers to equitable care.
Explore how we are engineering for greater tech equity.
We’re partnering with professional and regulatory groups because health equity cannot be achieved alone.
Find out how we’re working with industry partners to accelerate progress.
Listen to what led us to open a clinical physiology lab that recruits diverse participants that represent patients across all skin tones.
See independent evaluation at Open Oximetry, where each Nellcor™ system passed preliminary validation for patients of all skin tones.‡ The Open Oximetry project was created to improve the safety and precision of pulse oximeters in all populations.
Performs in accordance with 2013 FDA premarket notification submissions guidance and ISO 80601-2-61 (2017). Performance data from healthy volunteers may not accurately represent performance in real world patient populations. The information displayed here shall not be construed as an endorsement by Open Oximetry.
Learn how to bring more equitable outcomes to your patients.
At Medtronic, we understand that no issue in healthcare can be solved by a single group. We take our responsibility as a trusted industry leader to heart and seek out partners that are also driven to achieve equitable care for all. Together, we’re making collective progress in addressing technology bias in pulse oximetry.
PARTNERING TO RAISE
THE BAR
We take pride in representing pulse oximeter manufacturers with our advocacy and policy work with organizations like the International Organization for Standardization (ISO), the Open Oximetry project, and the Advisory Committee of the Food & Drug Administration (FDA).
In these partnerships, we evaluate and share data and findings to help evolve standards. Together, we’re increasing our understanding of the limitations and the possibilities of pulse oximetry.
PARTNERING ON SHARED MISSIONS
We’re leveraging our long-standing relationships with healthcare professional associations to support health equity initiatives. In our partnership with the Advanced Medical Technology Association (AdvaMed), we’re increasing diversity in clinical trials. Our work with the American Nursing Association (ANA) includes a grant for a special report in the American Nurse Journal about pulse oximetry and skin pigmentation. We’ve also partnered with the Anesthesia Patient Safety Foundation (APSF) to create patient safety resources and promote research through the Patient Safety and Healthcare Equity grant.
PARTNERING TO EDUCATE CLINICIANS
From live events to meaningful webinars, Medtronic and our partner organizations share a commitment to advancing health equity through collaborative partnerships and shared learnings. We connect with professional associations like the American Association of Critical-Care Nurses (AACN), the American Organization for Nursing Leadership (AONL), and the National Black Nurses Association (NBNA) to teach their members how to mitigate technology bias and make confident patient care decisions with pulse oximetry.
The Nellcor™ pulse oximetry monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.
TM* Third–party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Based on study (not funded by Medtronic) that enrolled 146 healthy subjects in the 92-96% saturation range and examined paired readings from Nellcor™ N-595 and Masimo Radical 7™* pulse oximeters generated simultaneously. This study was not designed for head-to-head comparison of the respective devices.
Performs in accordance with 2013 FDA premarket notification submissions guidance and ISO 80601-2-61 (2017). Performance data from healthy volunteers may not accurately represent performance in real world patient populations. The information displayed here shall not be construed as an endorsement by Open Oximetry.
Gudelunas MK, Lipnick M, Hendrickson C, et al. Low perfusion and missed diagnosis of hypoxemia by pulse oximetry in darkly pigmented skin: a prospective study. Anesth Analg. 2024;138(3):552–561. doi:10.1213/ANE.0000000000006755.
